Details

Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 26, 2026 · edition #6
Timestamp: 2026-01-26T00:15:31.135Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-casirivimab-imdevimab-covid19.html
Replay URL: https://replay.healtharchive.ca/job-6/20260126001531/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-casirivimab-imdevimab-covid19.html#ha_snapshot=414397
ID: 414397
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots